Repeated Low-Level Red-Light Therapy for Myopia-global Clinical Experiences
Date: 20/11/2024 (ACST)
Venue: https://us06web.zoom.us/webinar/register/WN_buoceF_DSta-HGITQ884KA, 2019, AUSTRALIA
Provider: Mivision
Contact: Nikki Byrne, [E] nikki@mivision.com.au, [P] 02 8336 8616
Activity Outline
Hear from three international experts from Spain, Norway and Japan discuss their feedback thus far on Eyerising International’s patented repeated low-level red-light therapy (RLRL). First, Dr Aleksandar Stojanovic will take us through his hands-on experiences with RLRL in Norway and ongoing 12-month European real-world study. Next, Dr Tae Igarashi-Yokoi will delve into the 12-month results of her trial on highly myopic children, as well as discuss her practical observations having now introduced RLRL at Tokyo Medical and Dental University. Finally, Dr Fernando Fernandez Velazquez will explore his 6 and 12-month results of his trial examining the adjunct use of RLRL with orthokeratology.
Learning Objectives
- Understand the practicalities of how to implement Repeated Low-Level Red-Light therapy in practice
- Be aware of global clinical evidence supporting its use in the management of myopia
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| Repeated Low-Level Red-Light Therapy for Myopia-global Clinical Experiences |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 1.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |